<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02324140</url>
  </required_header>
  <id_info>
    <org_study_id>041/09_2</org_study_id>
    <nct_id>NCT02324140</nct_id>
  </id_info>
  <brief_title>Inflammatory Response in Aortic Valve Replacement</brief_title>
  <official_title>The Impact of Genetic Variability on Perioperative Morbidity and Mortality. Substudy: Inflammatory Response in Patients Undergoing Aortic Valve Replacement.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates inflammatory and antiinflammatory response in patients with severe
      aortic valve stenosis needing either surgical treatment (surgical aortic valve replacement)
      or interventional cardiology treatment (transcatheter aortic valve implantation using the
      transfemoral access route or the transapical access route).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background

      Surgical and interventional therapy for aortic valve stenosis exposes the patients to a
      immune reaction, which is different depending on the type of the treatment. In this study,
      the investigators would like to better understand the inflammatory and antiinflammatory
      response in this patient population by monitoring the perioperative cytokine response
      (interleukins), the human leukocyte antigen expression (HLA-DR) and assessing soluble plasma
      factors (CD62L) involved in inflammatory processes.

      Objective

      Characterisation of inflammatory and antiinflammatory response in patients receiving aortic
      valve prosthesis selected for different treatment options.

      Methods

      Whole blood analysis at different time points (preoperatively, 4 / 24 /48 hours
      postoperatively) for different inflammatory and antiinflammatory markers: IL-6, IL-8, IL-10,
      CRP, TNF, soluble CD62L.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatory response, as determined by whole blood analysis of inflammatory biomarkers (IL-6, CRP, TNF alpha, CD62L)</measure>
    <time_frame>Perioperative period ending after 48 hours postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anti-inflammatory response, as determined by whole blood analysis of inflammatory biomarkers (IL-8, IL-10)</measure>
    <time_frame>Perioperative period ending after 48 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>In-hospital treatment until discharge (7-10 days)</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">101</enrollment>
  <condition>Inflammation</condition>
  <condition>Systemic Inflammatory Response Syndrome</condition>
  <condition>Thoracic Surgery</condition>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Minimized extracorporeal circulation</arm_group_label>
    <description>Patients with severe aortic valve stenosis undergoing surgical aortic valve replacement using the minimized extracorporeal circulation (MECC, group 1)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional extracorporeal circulation</arm_group_label>
    <description>Patients with severe aortic valve stenosis undergoing surgical aortic valve replacement using the conventional extracorporeal circulation (CECC, group 2)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcatheter aortic valve implantation, transfemoral access</arm_group_label>
    <description>Patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation using the transfemoral access route</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcatheter aortic valve implantation, transapical access</arm_group_label>
    <description>Patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation using the transapical access route</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole blood analysis</intervention_name>
    <description>In all fours groups of patients we investigate inflammatory and antiinflammatory response to the surgical and interventional treatment by analyzing changes in the concentration of interleukins, C-reactive protein, soluble CD62L and HLA-DR.</description>
    <arm_group_label>Minimized extracorporeal circulation</arm_group_label>
    <arm_group_label>Conventional extracorporeal circulation</arm_group_label>
    <arm_group_label>Transcatheter aortic valve implantation, transfemoral access</arm_group_label>
    <arm_group_label>Transcatheter aortic valve implantation, transapical access</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood analysis
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe aortic valve stenosis selected for surgical aortic valve replacement
        or transcatheter aortic valve implantation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Severe aortic valve stenosis

          -  Surgical aortic valve replacement

          -  Transcatheter aortic valve implantation

          -  No previous inflammatory condition

        Exclusion Criteria

          -  Missing informed consent

          -  Treatment with corticosteroids

          -  Treatment with antibiotics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank St√ºber, MD, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Dep. Anesthesiology and pain Therapy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dep. Anesthesiology and Pain Therapy</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2014</study_first_submitted>
  <study_first_submitted_qc>December 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2014</study_first_posted>
  <last_update_submitted>July 13, 2015</last_update_submitted>
  <last_update_submitted_qc>July 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

